Clinical TrialsSearch results
Number of results: 58449
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A 26-Week, 2-Part Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
- Obesity
- Kawai Norisuke
- 2021-03-14
Other
- A 3D gait analysis after deep brain stimulation in Parkinson's disease
- Parkinson's disease
- Juntendo University Hospital
- 2017-12-19
Other
- A 3D-OCT investigation into coronary artery bifurcation lesion stent implantation technique
- Coronary artery bifurcation disease
- 3D-OCT investigators
- 2014-08-04
Other
- A 78-week trial comparing the effect and safety of once weekly insulin icodec and once daily insulin glargine 100 units/mL, both in combination with non-insulin anti-diabetic treatment, in insulin naive subjects with type 2 diabetes.(NN1436-4477)
- type 2 diabetes
- Nishiba Hiroko
- 2020-12-14
Other
- A ACLINICAL STUDY TO EVALUATE THE INFLUENCE OF DEGARELIX ON PROSTATE VOLUME IN PATIENTS WITH PROSTATE CANCER UNDERGOING PROSTATE BRACHYTHERAPY WITH PERMANENT SEED IMPLANTATION
- prostate cancer
- Department of Urology, Keio University School of Medicine
- 2014-09-12
Other
- A backward-looking observational study of the association between sleep, diet, quality of life, treatment burden and long-term glycemic control and complications in patients with diabetes
- type 2 diabetes
- Department of Endocrinology and Metabolism, Yokohama City University Medical Center
- 2020-11-04
Other
- A bioequivalence study of ACT-541468 25 and 50mg tablet
- Insomnia
- Kawashima Takayuki
- 2022-05-19
Other
- A Biomarker Analysis of Nivolumab in Previously Treated Advanced Gastric Cancer(WJOG10417GTR)
- Gastric Cancer
- West Japan Oncology Group
- 2018-05-24
Other
- A biomarker analysis of plasma and
tumor DNA in afatinib-treatedpatients with EGFR mutation-positive advanced adenocarcinoma of the lung.
- adenocarcinoma of the lung
- Clinical Research Support Center Kyushu
- 2014-05-07
Other
- A biomarker study of soluble immune markers in stage II-IIIA non-small cell lung cancer (WJOG12319LTR)
- Resectable stage II-IIIA non-small cell lung cancer
- West Japan Oncology Group
- 2019-08-26